Skip to main content

Sulfonylurea

  • Reference work entry
  • First Online:
  • 131 Accesses

A group of compounds that stimulate insulin production by regulating insulin secretion and lower blood sugar level; it is used to treat patients with non-insulin dependent diabetes. These drugs interact with the sulfonylurea receptor of pancreatic β cells and inhibit the conductance of ATP-dependent K+ ion channels. Reduction of potassium exit activates the inward rectifying Ca2+ channels and promotes exocytosis. Sulfonylureas are inhibitors of the acetolactate synthase enzyme and there are also sulfonylurea herbicides. ion channels, diabetes, herbicides

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   999.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   549.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer Science+Business Media

About this entry

Cite this entry

(2008). Sulfonylurea. In: Encyclopedia of Genetics, Genomics, Proteomics and Informatics. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-6754-9_16348

Download citation

Publish with us

Policies and ethics